Department of Medical Microbiology and Immunology, School of Medicine, University of California, 3327 Tupper Hall, 1 Shields Ave., Davis, CA 95616, USA.
J Virol. 2010 Nov;84(21):11020-9. doi: 10.1128/JVI.00980-10. Epub 2010 Aug 18.
A small percentage of human immunodeficiency virus (HIV)-infected individuals, termed elite controllers, are able to spontaneously control HIV replication in blood. As the gastrointestinal mucosa is an important site of HIV transmission and replication as well as CD4+ T-cell depletion, it is important to understand the nature of the immune responses occurring in this compartment. Although the role of the HIV-specific CD8+ T-cell responses in mucosal tissues has been described, few studies have investigated the role of mucosal HIV-specific CD4+ T cells. In this study, we assessed HIV-specific CD4+ T-cell responses in the rectal mucosa of 28 "controllers" (viral load [VL] of <2,000 copies/ml), 14 "noncontrollers" (VL of >10,000 copies/ml), and 10 individuals on highly active antiretroviral therapy (HAART) (VL of <75 copies/ml). Controllers had higher-magnitude Gag-specific mucosal CD4+ T-cell responses than individuals on HAART (P<0.05), as measured by their ability to produce gamma interferon (IFN-γ), interleukin-2 (IL-2), tumor necrosis factor alpha (TNF-α), and macrophage inflammatory protein 1β (MIP-1β). The frequency of polyfunctional mucosal CD4+ T cells was also higher in controllers than in noncontrollers or individuals on HAART (P<0.05). Controllers with the strongest HIV-specific CD4+ T-cell responses possessed class II HLA alleles, HLA-DRB113 and/or HLA-DQB106, previously associated with a nonprogression phenotype. Strikingly, individuals with both HLA-DRB113 and HLA-DQB106 had highly polyfunctional mucosal CD4+ T cells compared to individuals with HLA-DQB1*06 alone or other class II alleles. The frequency of polyfunctional CD4+ T cells in rectal mucosa positively correlated with the magnitude of the mucosal CD8+ T-cell response (Spearman's r=0.43, P=0.005), suggesting that increased CD4+ T-cell "help" may be important in maintaining strong CD8+ T-cell responses in the gut of HIV controllers.
一小部分人类免疫缺陷病毒(HIV)感染者被称为精英控制器,他们能够自发地控制血液中的 HIV 复制。由于胃肠道黏膜是 HIV 传播和复制以及 CD4+T 细胞耗竭的重要部位,因此了解发生在该部位的免疫反应的性质非常重要。虽然已经描述了 HIV 特异性 CD8+T 细胞反应在黏膜组织中的作用,但很少有研究调查黏膜 HIV 特异性 CD4+T 细胞的作用。在这项研究中,我们评估了 28 名“控制器”(病毒载量[VL] <2000 拷贝/ml)、14 名“非控制器”(VL >10000 拷贝/ml)和 10 名接受高效抗逆转录病毒治疗(HAART)(VL <75 拷贝/ml)直肠黏膜中的 HIV 特异性 CD4+T 细胞反应。与接受 HAART 的个体相比(P<0.05),控制器具有更高幅度的 Gag 特异性黏膜 CD4+T 细胞反应,如通过其产生伽马干扰素(IFN-γ)、白细胞介素-2(IL-2)、肿瘤坏死因子 alpha(TNF-α)和巨噬细胞炎症蛋白 1β(MIP-1β)的能力来衡量。与非控制器或接受 HAART 的个体相比,控制器中多效性黏膜 CD4+T 细胞的频率也更高(P<0.05)。具有最强 HIV 特异性 CD4+T 细胞反应的控制器具有 II 类 HLA 等位基因 HLA-DRB113 和/或 HLA-DQB106,这些等位基因先前与非进展表型相关。引人注目的是,同时具有 HLA-DRB113 和 HLA-DQB106 的个体与仅具有 HLA-DQB1*06 或其他 II 类等位基因的个体相比,具有高度多效性的黏膜 CD4+T 细胞。直肠黏膜中多效性 CD4+T 细胞的频率与黏膜 CD8+T 细胞反应的幅度呈正相关(Spearman r=0.43,P=0.005),这表明增加 CD4+T 细胞“帮助”可能对维持 HIV 控制器肠道中强大的 CD8+T 细胞反应很重要。